PLEKHA6 variants identified in 24 patients with idiopathic hypogonadotropic hypogonadism across two cohorts
This cohort study analyzed 1,822 patients with idiopathic hypogonadotropic hypogonadism (IHH) across two independent cohorts. The primary objective was the identification of PLEKHA6 variants and their segregation with the disease. No comparator group was utilized as this was a discovery-focused genetic analysis.
The study identified 18 distinct PLEKHA6 variants in 24 patients from 20 unrelated families, accounting for 1.3% of the total cohort. These variants segregated with disease under both autosomal recessive and autosomal dominant inheritance patterns, with variable penetrance observed in the dominant cases.
Secondary analyses assessed PLEKHA6 expression in the postmortem human hypothalamus and kisspeptin secretion in cell-based assays. PLEKHA6 was robustly expressed in the hypothalamus and showed clear colocalization with neurokinin B. Patient variants significantly impaired kisspeptin secretion in these assays. PLEKHA6 is a novel IHH gene and the first reported regulator of kisspeptin secretion from the kisspeptin-neurokinin B-dynorphin (KNDy) neurons.
Safety data, adverse events, and discontinuations were not reported as this was a genetic discovery study. Limitations include the observational nature of the cohort design and the fact that causality is inferred from segregation rather than randomized intervention. The practice relevance lies in expanding the genetic differential for IHH, though clinical application requires further validation.